March 31, 2017 / 10:33 AM / 8 months ago

BRIEF-IDMC starts interim analysis of Mesoblast's phase 3 heart failure trial

March 31 (Reuters) - Mesoblast Ltd:

* Independent Data Monitoring Committee initiates process for interim analysis of Mesoblast’S phase 3 chronic heart failure trial

* Says interim analysis dataset has been locked and will be analyzed and reviewed by trial’s independent statisticians

* Mesoblast Ltd - throughout review process, co to remain blinded to individual treatment allocation as well as grouped safety and efficacy data

* Mesoblast Ltd - IDMC will review and interpret results of interim analysis and provide recommendations shortly Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below